Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations

por Callebaut, Christian, Liu, Yang, Babusis, Darius, Ray, Adrian, Miller, Michael, Kitrinos, Kathryn
Publicado 2017

Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction

por Xu, Xiaojun, Thai, Hong, Kitrinos, Kathryn M., Xia, Guoliang, Gaggar, Anuj, Paulson, Matthew, Ganova-Raeva, Lilia, Khudyakov, Yury, Lara, James
Publicado 2016

Complex genetic encoding of the hepatitis B virus on-drug persistence

por Thai, Hong, Lara, James, Xu, Xiaojun, Kitrinos, Kathryn, Gaggar, Anuj, Chan, Henry Lik Yuen, Xia, Guo-liang, Ganova-Raeva, Lilia, Khudyakov, Yury
Publicado 2020

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

por Gordon, Stuart C, Krastev, Zahary, Horban, Andrzej, Petersen, Jörg, Sperl, Jan, Dinh, Phillip, Martins, Eduardo B, Yee, Leland J, Flaherty, John F, Kitrinos, Kathryn M, Rustgi, Vinod K, Marcellin, Patrick
Publicado 2013

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

por Buti, Maria, Tsai, Naoky, Petersen, Joerg, Flisiak, Robert, Gurel, Selim, Krastev, Zahary, Aguilar Schall, Raul, Flaherty, John F., Martins, Eduardo B., Charuworn, Prista, Kitrinos, Kathryn M., Mani Subramanian, G., Gane, Edward, Marcellin, Patrick
Publicado 2014